CellBion Co., Ltd. (KOSDAQ:308430)

CellBion Statistics

Total Valuation

CellBion has a market cap or net worth of KRW 386.87 billion. The enterprise value is 372.58 billion.

Market Cap	386.87B
Enterprise Value	372.58B

Important Dates

The next estimated earnings date is Monday, April 13, 2026.

Earnings Date	Apr 13, 2026
Ex-Dividend Date	n/a

Share Statistics

CellBion has 12.83 million shares outstanding.

Current Share Class	12.83M
Shares Outstanding	12.83M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.41%
Owned by Institutions (%)	3.59%
Float	8.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	198.90
PB Ratio	16.98
P/TBV Ratio	17.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-49.19
EV / Sales	191.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-53.09

Financial Position

The company has a current ratio of 11.10, with a Debt / Equity ratio of 0.37.

Current Ratio	11.10
Quick Ratio	10.28
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	-1.20
Interest Coverage	-60.17

Financial Efficiency

Return on equity (ROE) is -28.93% and return on invested capital (ROIC) is -16.40%.

Return on Equity (ROE)	-28.93%
Return on Assets (ROA)	-14.81%
Return on Invested Capital (ROIC)	-16.40%
Return on Capital Employed (ROCE)	-25.03%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.06
Inventory Turnover	4.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +79.41% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+79.41%
50-Day Moving Average	29,166.00
200-Day Moving Average	23,934.55
Relative Strength Index (RSI)	51.66
Average Volume (20 Days)	103,699

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellBion had revenue of KRW 1.95 billion and -7.57 billion in losses. Loss per share was -591.00.

Revenue	1.95B
Gross Profit	83.39M
Operating Income	-8.24B
Pretax Income	-7.57B
Net Income	-7.57B
EBITDA	-8.00B
EBIT	-8.24B
Loss Per Share	-591.00

Balance Sheet

The company has 22.71 billion in cash and 8.42 billion in debt, with a net cash position of 14.29 billion or 1,113.49 per share.

Cash & Cash Equivalents	22.71B
Total Debt	8.42B
Net Cash	14.29B
Net Cash Per Share	1,113.49
Equity (Book Value)	22.79B
Book Value Per Share	1,775.83
Working Capital	22.84B

Cash Flow

In the last 12 months, operating cash flow was -5.55 billion and capital expenditures -1.47 billion, giving a free cash flow of -7.02 billion.

Operating Cash Flow	-5.55B
Capital Expenditures	-1.47B
Depreciation & Amortization	778.64M
Net Borrowing	-518.46M
Free Cash Flow	-7.02B
FCF Per Share	-546.90

Margins

Gross Margin	4.29%
Operating Margin	-423.87%
Pretax Margin	-389.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CellBion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.96%
FCF Yield	-1.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CellBion has an Altman Z-Score of 10.31 and a Piotroski F-Score of 2.

Altman Z-Score	10.31
Piotroski F-Score	2